Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulax in Essential Blepharospasm
NCT03641950Phase 4Completed
- Sponsor
- Hugel
- Start
- Apr 2015
- Primary completion
- May 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in benign essential blepharospasm (BEB), sponsored by Hugel. Started Apr 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
benign essential blepharospasm (BEB)
Beyond the preview
Go deeper on NCT03641950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03641950.